| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.084 | 19.881 | 19.956 | 20.036 | 20.015 | 22.523 | 22.539 | 23.016 | 23.006 | 22.905 |
| Total Income - EUR | 20.084 | 19.881 | 19.956 | 20.036 | 20.015 | 22.523 | 22.539 | 23.016 | 23.006 | 22.905 |
| Total Expenses - EUR | 17.326 | 4.454 | 16.700 | 14.877 | 9.678 | 8.631 | 2.973 | 21.083 | 22.746 | 16.382 |
| Gross Profit/Loss - EUR | 2.758 | 15.426 | 3.256 | 5.160 | 10.336 | 13.892 | 19.566 | 1.933 | 259 | 6.524 |
| Net Profit/Loss - EUR | 2.155 | 14.832 | 2.658 | 4.559 | 9.736 | 13.216 | 18.890 | 1.356 | 30 | 6.295 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Medinf Alfa Grup S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16 | 15 | 15 | 15 | 15 | 14 | 14 | 14 | 14 | 14 |
| Current Assets | 3.941 | 16.600 | 4.400 | 6.271 | 11.419 | 15.654 | 34.201 | 12.045 | 12.643 | 7.400 |
| Inventories | 338 | 143 | 0 | 0 | 0 | 0 | 396 | 198 | 0 | 830 |
| Receivables | 955 | 16.108 | 1.055 | 1.092 | 11.149 | 13.464 | 16.031 | 7.532 | 10.064 | 2.935 |
| Cash | 2.647 | 350 | 3.345 | 5.179 | 270 | 2.190 | 17.774 | 4.315 | 2.579 | 3.635 |
| Shareholders Funds | 3.806 | 16.467 | 4.264 | 6.136 | 11.283 | 15.498 | 34.045 | 11.923 | 11.916 | 6.201 |
| Social Capital | 1.584 | 1.568 | 1.541 | 1.513 | 1.484 | 1.455 | 1.423 | 1.428 | 1.423 | 1.415 |
| Debts | 150 | 149 | 151 | 150 | 151 | 170 | 171 | 136 | 741 | 1.213 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Medinf Alfa Grup S.r.l.